These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 24078483)

  • 1. The growth of human scalp hair mediated by visible red light laser and LED sources in males.
    Lanzafame RJ; Blanche RR; Bodian AB; Chiacchierini RP; Fernandez-Obregon A; Kazmirek ER
    Lasers Surg Med; 2013 Oct; 45(8):487-95. PubMed ID: 24078483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The growth of human scalp hair in females using visible red light laser and LED sources.
    Lanzafame RJ; Blanche RR; Chiacchierini RP; Kazmirek ER; Sklar JA
    Lasers Surg Med; 2014 Oct; 46(8):601-7. PubMed ID: 25124964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-level light therapy for androgenetic alopecia: a 24-week, randomized, double-blind, sham device-controlled multicenter trial.
    Kim H; Choi JW; Kim JY; Shin JW; Lee SJ; Huh CH
    Dermatol Surg; 2013 Aug; 39(8):1177-83. PubMed ID: 23551662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-level laser therapy for the treatment of androgenetic alopecia in Thai men and women: a 24-week, randomized, double-blind, sham device-controlled trial.
    Suchonwanit P; Chalermroj N; Khunkhet S
    Lasers Med Sci; 2019 Aug; 34(6):1107-1114. PubMed ID: 30569416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Approach to Treating Androgenetic Alopecia in Females With Photobiomodulation (Low-Level Laser Therapy).
    Friedman S; Schnoor P
    Dermatol Surg; 2017 Jun; 43(6):856-867. PubMed ID: 28328705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia.
    Blume-Peytavi U; Lönnfors S; Hillmann K; Garcia Bartels N
    J Am Acad Dermatol; 2012 May; 66(5):794-800. PubMed ID: 21875758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of low-level light for hair growth: part I.
    Avram MR; Rogers NE
    J Cosmet Laser Ther; 2009 Jun; 11(2):110-7. PubMed ID: 19466643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of hair loss in men with androgenetic alopecia (male pattern hair loss): long-term (5-year) controlled observational data in placebo-treated patients.
    Kaufman KD; Girman CJ; Round EM; Johnson-Levonas AO; Shah AK; Rotonda J
    Eur J Dermatol; 2008; 18(4):407-11. PubMed ID: 18573713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia.
    Gubelin Harcha W; Barboza Martínez J; Tsai TF; Katsuoka K; Kawashima M; Tsuboi R; Barnes A; Ferron-Brady G; Chetty D
    J Am Acad Dermatol; 2014 Mar; 70(3):489-498.e3. PubMed ID: 24411083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.
    Lucky AW; Piacquadio DJ; Ditre CM; Dunlap F; Kantor I; Pandya AG; Savin RC; Tharp MD
    J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HairMax LaserComb laser phototherapy device in the treatment of male androgenetic alopecia: A randomized, double-blind, sham device-controlled, multicentre trial.
    Leavitt M; Charles G; Heyman E; Michaels D
    Clin Drug Investig; 2009; 29(5):283-92. PubMed ID: 19366270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, placebo-controlled randomized trial evaluating the ability of low-level laser therapy to improve the appearance of cellulite.
    Jackson RF; Roche GC; Shanks SC
    Lasers Surg Med; 2013 Mar; 45(3):141-7. PubMed ID: 23508376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of a Low-Level Light Therapy for Androgenetic Alopecia: A 24-Week, Randomized, Double-Blind, Self-Comparison, Sham Device-Controlled Trial.
    Mai-Yi Fan S; Cheng YP; Lee MY; Lin SJ; Chiu HY
    Dermatol Surg; 2018 Nov; 44(11):1411-1420. PubMed ID: 29957664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-level laser/light therapy for androgenetic alopecia.
    Gupta AK; Lyons DC; Abramovits W
    Skinmed; 2014; 12(3):145-7. PubMed ID: 25134310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of low-level laser therapy in the treatment of hair growth: An Egyptian experience.
    Amer M; Nassar A; Attallah H; Amer A
    Dermatol Ther; 2021 May; 34(3):e14940. PubMed ID: 33713522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of long-pulsed alexandrite and Nd:YAG lasers, individually and in combination, for leg hair reduction: an assessor-blinded, randomized trial with 18 months of follow-up.
    Davoudi SM; Behnia F; Gorouhi F; Keshavarz S; Nassiri Kashani M; Rashighi Firoozabadi M; Firooz A
    Arch Dermatol; 2008 Oct; 144(10):1323-7. PubMed ID: 18936396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: a randomized, double-blind, placebo-controlled, phase III study.
    Eun HC; Kwon OS; Yeon JH; Shin HS; Kim BY; Ro BI; Cho HK; Sim WY; Lew BL; Lee WS; Park HY; Hong SP; Ji JH
    J Am Acad Dermatol; 2010 Aug; 63(2):252-8. PubMed ID: 20605255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Finasteride increases anagen hair in men with androgenetic alopecia.
    Van Neste D; Fuh V; Sanchez-Pedreno P; Lopez-Bran E; Wolff H; Whiting D; Roberts J; Kopera D; Stene JJ; Calvieri S; Tosti A; Prens E; Guarrera M; Kanojia P; He W; Kaufman KD
    Br J Dermatol; 2000 Oct; 143(4):804-10. PubMed ID: 11069460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia.
    Price VH; Roberts JL; Hordinsky M; Olsen EA; Savin R; Bergfeld W; Fiedler V; Lucky A; Whiting DA; Pappas F; Culbertson J; Kotey P; Meehan A; Waldstreicher J
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):768-76. PubMed ID: 11050579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global photographic assessment of men aged 18 to 60 years with male pattern hair loss receiving finasteride 1 mg or placebo.
    Olsen EA; Whiting DA; Savin R; Rodgers A; Johnson-Levonas AO; Round E; Rotonda J; Kaufman KD;
    J Am Acad Dermatol; 2012 Sep; 67(3):379-86. PubMed ID: 22325459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.